Rezera (RZRA.US) submits IPO application: Oral NLRP3 inhibitor pipeline advances, PAD Phase III trial scheduled to launch in 2027
智通财经2026/10/23 08:30Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Smart Finance APP has learned that Rezera is a biotechnology company ready for phase III clinical trials, developing oral NLRP3 inhibitors for inflammatory diseases. On Wednesday, the company submitted an IPO application to the U.S. Securities and Exchange Commission (SEC), with a filing showing a proposed fundraising amount of 100 million US dollars (placeholder figure).
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!
You may also like
India’s crude oil imports surged in September as Middle Eastern supplies resumed
智通财经•2026/10/23 09:06
Crypto prices
More
Bitcoin
BTC
$81,686.87
-0.03%
Ethereum
ETH
$2,403.17
-0.03%
Tether USDt
USDT
$0.9987
-0.01%
BNB
BNB
$744.18
+1.57%
XRP
XRP
$1.32
-0.10%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$104.45
+0.80%
TRON
TRX
$0.3295
-0.27%
Zcash
ZEC
$1,229.55
-0.06%
Hyperliquid
HYPE
$78.56
+0.77%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now